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Abstract: Natural products using plants have received considerable attention because of their 
potential to treat various diseases. Arrabidaea chica (Humb. & Bonpl.) B. Verlot is a native 
tropical American vine with healing properties employed in folk medicine for wound heal-
ing, inflammation, and gastrointestinal colic. Applying nanotechnology to plant extracts has 
revealed an advantageous strategy for herbal drugs considering the numerous features that 
nanostructured systems offer, including solubility, bioavailability, and pharmacological activity 
enhancement. The present study reports the preparation and characterization of chitosan–sodium 
tripolyphosphate nanoparticles (NPs) charged with A. chica standardized extract (AcE). Particle 
size and zeta potential were measured using a Zetasizer Nano ZS. The NP morphological char-
acteristics were observed using scanning electron microscopy. Our studies indicated that the 
chitosan/sodium tripolyphosphate mass ratio of 5 and volume ratio of 10 were found to be the 
best condition to achieve the lowest NP sizes, with an average hydrodynamic diameter of 150±13 
nm and a zeta potential of +45±2 mV. Particle size decreased with AcE addition (60±10.2 nm), 
suggesting an interaction between the extract’s composition and polymers. The NP biocompat-
ibility was evaluated using human skin fibroblasts. AcE-NP demonstrated capability of main-
taining cell viability at the lowest concentrations tested, stimulating cell proliferation at higher 
concentrations. Antiulcerogenic activity of AcE-NP was also evaluated with an acute gastric 
ulcer experimental model induced by ethanol and indomethacin. NPs loaded with A. chica extract 
reduced the ulcerative lesion index using lower doses compared with the free extract, suggesting 
that extract encapsulation in chitosan NPs allowed for a dose reduction for a gastroprotective 
effect. The AcE encapsulation offers an approach for further application of the A. chica extract 
that could be considered a potential candidate for ulcer-healing pharmaceutical systems.
Keywords: natural product, Arrabidaea chica, chitosan, nanoparticle, plant extract, herbal 
drug, ulcer healing
Introduction
Plants have been a rich source of bioactive compounds for millennia, while the use 
of plant derivatives for the production of nanobiotechnological products has gained 
scientific and technological importance in recent years.1
Arrabidaea chica (Humb. & Bonpl.) B. Verlot (Bignoniaceae), popularly known 
as Crajiru, is a native tropical American vine employed in folk medicine for wound 
healing, inflammation, and gastrointestinal colic.2 Previous studies with A. chica 
demonstrated in vitro and in vivo healing properties,3 also increasing collagen content 
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during the tendon healing process.4 Antimicrobial,5 anti-
inflammatory,6 and antioxidant7 potentials of this species 
have also been reported.
Applying nanotechnology to plant extracts has revealed 
an advantageous strategy for herbal drugs considering the 
numerous features that nanostructured systems have to 
offer, including solubility, bioavailability, and pharma-
cological activity enhancement, protection from toxicity, 
sustained delivery, and protection from physical and chemi-
cal degradation.8,9 Currently, nanotechnological processes 
involving medicinal plants have provided several innovative 
delivery systems, including polymeric nanoparticles (NPs). 
These materials, made from biodegradable and biocompat-
ible polymers such as chitosan (CS), represent an option for 
controlled drug delivery.9
CS, a N-deacetylation product of chitin, a natural polysac-
charide, is mostly found in the exoskeleton of crustaceans, 
insects, and fungi.10 The molecular structure comprises a 
linear backbone linked through glycosidic bonds with random 
copolymer of β-(1–4)-linked d-glucosamine and N-acetyl-
d-glucosamine.11 Due to the protonation of amino groups, 
this polysaccharide can form polyelectrolyte complexes with 
negatively charged compounds. These complexes are formed 
simultaneously by mixing oppositely charged polyelectro-
lytes in solution without any chemical covalent cross-linker. 
In contrast to chemically cross-linked complexes, polyelec-
trolyte complexes are generally nontoxic, well tolerated, and 
biocompatible.10
Cross-linking CS with sodium tripolyphosphate (TPP) 
constitutes a mild and efficient method to achieve CS NPs. 
The particles are formed mainly through the electrostatic 
interaction between positively charged CS and negatively 
charged TPP molecules.12,13
The biomedical applications of CS include epithelial, 
bone, and dental tissue regeneration, wound dressing, drug 
delivery, as well as antimicrobial, antioxidant, and anti-
inflammatory properties.14–17 There is strong evidence of CS 
nanocarrier potential for many challenging drug delivery 
applications. Moreover, there is also indicative data regarding 
CS biocompatibility, which further supports the potential use 
in nanomedicine.11 The present research was conducted to 
formulate and develop strategies to improve the therapeutic 
efficacy of A. chica standardized extract employing CS NPs 
as a carrier. The process parameters were adjusted to achieve 
the best conditions for NP production. The NP system’s bio-
compatibility was evaluated using human fibroblasts. Gastric 
ulcer experimental models in rats were used to evaluate the 
antiulcerogenic activity of A. chica NPs.
Materials and methods
Plant material
A. chica Verlot (Bignoniaceae) leaves were collected at 
Chemical, Biological and Agricultural Pluridisciplinary 
Research Center, State University of Campinas experimental 
field (22°45′00″ south and 47°10′21″ west; Paulinia, Brazil). 
The corresponding voucher specimen (1348) was deposited 
at CPQBA-Herbarium. Genetic patrimony number autho-
rization 010150/2012-9 was issued by Conselho Nacional 
para o Desenvolvimento Científico e Tecnológico (CNPq) 
for this study.
extraction procedures
A. chica hydroalcoholic standardized extract (AcE) was 
obtained according to the method described by Jorge et al3 
and Paula et al18 with modifications. One kilogram of dried 
and ground leaves were extracted three times, using 5 L 
of acidified (0.3% citric acid) 70% hydroethanol solution 
throughout 1.5-hour periods, at room temperature, with 
mechanical stirring. The procedure was repeated a further 
couple of times. The extract was filtered and the organic 
solvent was removed under vacuum. The resulting crude 
extract was further dried using a Mini Spray Drier B-290, 
loop B-295 (BÜCHI Labortechnik AG, Flawil, Switzerland). 
The inlet temperature was 100°C±2°C and the outlet tem-
perature was 60°C±2°C, with 250 mL⋅hour-1 aspiration flow 
with N
2
, 414 L⋅hour-1 injection pressure, and 5 mL⋅minute-1 
feed flow at room temperature.
Phytochemical analysis
Analytical analysis was adapted from a previously described 
method by Wen et al19 performed with a Shimadzu series 
high-pressure liquid chromatography (HPLC) system 
equipped with an online degasser (DUG-2A), quaternary 
pump (LC-10AT), autosampler (SIL 20A HT), column 
heater (CTO 10AS Vp), and photodiode array detector 
(DAD) (SPD-M10Vp) (Shimadzu Corporation, Kyoto, 
Japan). Instrument control and data analysis were carried 
out using Class VP 6.13 edition; C18 columns were used 
(5 µm, 4.6×250 mm; Gemini®; Phenomenex, Torrance, 
CA, USA). The flow rate of the mobile phase was kept at 
1.0 mL⋅minute-1. Mobile phase A was water that contained 
0.2% H
3
PO
4
, and phase B was methanol. The gradient 
conditions were as follows: 0–5 mintues, 45% phase B; 
5–10 minutes, 90% phase B; 10–16 minutes, 30%–45% phase 
B; 16–18 minutes, 45% phase B; 18–25 minutes, 45%–80% 
phase B; 20–30 minutes, 100% phase B; and 30–45 minutes, 
45% phase B. The column temperature was controlled at 
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35°C. The injection volume was 20 µL. The detection DAD 
wavelength was set at 470 nm.
Preparation of cs-TPP NPs
CS-TPP NPs were prepared according to the ionic gelation 
method.12 Briefly, 1% (w/v) CS solutions were prepared 
by dissolving CS (PROTASAN UP CL 213; molecular 
weight .150 kDa, 87% deacetylated; FMC BioPolymer 
AS, Sandvika, Norway) into Milli-Q® water. To evaluate the 
influence of the cross-linking agent concentration, different 
amounts of TPP (Sigma-Aldrich Co., St Louis, MO, USA) 
were dissolved in Milli-Q® water to form TPP solutions. 
NPs were formed by adding TPP solution dropwise onto a 
CS solution under mechanical stirring (ULTRA-TURRAX®) 
(7,200 rpm). Thereafter, the CS-TPP particle suspension was 
processed under ultrasonication (Sonics VC 750) for 5 min-
utes, producing CS particles with controlled particle sizes.
ace encapsulation
AcE was incorporated into the TPP solution prior to NP for-
mation. AcE was added in different concentrations of 10%, 
15%, or 25% with respect to the total amount of CS used for 
particle preparation. The NP dispersion was dialyzed against 
distilled water for 24 hours using a cellulose membrane 
(Spectra/Por dialysis membrane; molecular weight cutoff of 
3,500 Da) to remove the nonencapsulated AcE. The amount 
of nonentrapped AcE recovered in the external aqueous 
phase after dialysis was quantified using a calibration curve 
obtained from different AcE solutions of known concen-
tration, by measuring absorbance of the external aqueous 
dialyzed solution at 485 nm on a PerkinElmer Instrument 
spectrometer Lambda 35 ultraviolet–visible spectrophotom-
eter (PerkinElmer Inc., Waltham, MA, USA). The percentage 
of encapsulate efficiency (EE) was defined as:
 %EE = {[(AcE)
o
 – (AcE)
i
]/(AcE)
o
}
 
×100 (1)
where (AcE)
o
 is the total AcE amount added and (AcE)
i 
is the nonencapsulated AcE amount. The sponges were pre-
pared by the direct freeze–drying20 of NP dispersions.
Measurement of NP size and zeta 
potential
Measurement of the average particle size and particle size 
distribution, polydispersity index, and zeta potential (ZP) 
of CS-TPP NPs was performed using a Zetasizer Nano ZS 
(Malvern Instruments, Malvern, UK). Hydrodynamic diam-
eter and polydispersity index were determined by dynamic 
light scattering. The intensity of light scattered was used to 
calculate the mean hydrodynamic diameter (Z-average mean), 
based on the Stokes–Einstein equation, which assumes that 
the particle is spherical. For each sample, the data average 
and standard deviation (SD) were calculated from at least 
five measurements.
ZP analysis was carried out using laser doppler elec-
trophoresis with 20 runs per measurement at 25°C. The 
ZPs were automatically calculated from the electrophoretic 
mobility using the Smoluchowski’s approximation:
 UE = 2*ε*z*f(ka)/3*η → z ≈ UE*η/ε (2)
where UE is the electrophoretical mobility, ε is the dielectric 
constant, z is the ZP, f(ka) is Henry’s function, and η is the 
viscosity. This approximation is generally applied when 
the measurements are carried out in aqueous media, and it 
considers that Henry’s function takes a value of 3/2.
Morphology observation
The morphological characteristics of NPs were observed 
using a Hitachi SU8000 UHR Cold-Emission FE-SEM 
apparatus (Hitachi Ltd., Tokyo, Japan). Scanning electron 
microscopy (SEM) images were obtained using an accelerat-
ing voltage of 3 keV. Samples were prepared by deposition of 
the corresponding NP suspension (100 µL) over small glass 
disks (13 mm in diameter and 1 mm thick), and the solvent 
(H
2
O) was evaporated at room temperature. Finally, the 
samples were coated with chrome prior to examination.
cell culture conditions
The biological response was tested with human embryonic 
skin fibroblasts (Innoprot, Biscay, Spain). The culture 
medium was Dulbecco’s Modified Eagle’s Medium (DMEM) 
enriched with 4,500 mg⋅mL-1 glucose (Sigma-Aldrich Co.) 
supplemented with 10% fetal bovine serum (FBS), 200 mM 
l-glutamine, 100 units⋅mL-1 penicillin, and 100 mg⋅mL-1 
streptomycin, modified with HEPES (complete medium). 
The culture medium was carefully changed at selected times 
to avoid any disturbance to the culture conditions. Cells 
without treatment were used as a negative control.
cell viability assay
Cell viability (CV) of NP, AcE-NP, and AcE was assessed 
by a 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium 
bromide (MTT) assay.21,22 The AcE concentration tested 
corresponded to the amount of AcE loaded in the NPs (ratio 
of 20%). To evaluate the possibility of cytotoxic product 
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formation, the samples were set up in 5 mL of FBS-free 
supplemented DMEM and placed on a shaker at 37°C. The 
conditioned medium was collected and filtered at days 1, 2, 3, 
7, 10, 15, 21 and stored at -20°C until required. Fibroblasts 
were seeded at a density of 8×104 cells⋅mL-1 in complete 
medium into a sterile 96-well plate and incubated to conflu-
ence. CV was determined for the different NP concentrations 
(0.001–0.5 g⋅mL-1) in 1% FBS supplemented with DMEM. 
After 24 hours, the medium was replaced with the corre-
sponding sample and incubated at 37°C in humidified air 
with 5% CO
2
 for 24 hours, 48 hours, or 72 hours. An MTT 
solution (0.5 mg⋅mL-1) was prepared in warm FBS-free 
supplemented DMEM and plates were incubated at 37°C 
for 3–4 hours. Excess medium and MTT were removed and 
dimethyl sulfoxide (100 µL) was added to all wells in order 
to dissolve MTT taken up by the cells. Finally, the absorbance 
was measured with a BioTek Synergy HT detector using a 
test wavelength of 570 nm. CV (%) was calculated with the 
following equation:
 CV (%) = 100 × [(OD
S
 – OD
B
)/(OD
C 
– OD
B
)]. (3)
OD
S
, OD
B
, and OD
C
 are defined as the optical density for 
sample (S), blank (B) (culture medium without cells), and 
control (C), respectively.
animals
Adult male Wistar/Uni rats (200–300 g) were obtained from 
the Multidisciplinary Center for Biological Investigation 
on Laboratory Animals Sciences (CEMIB-UNICAMP). 
The animals were maintained at the animal facilities of the 
Pharmacology and Toxicology Division, CPQBA, University 
of Campinas (Campinas, Brazil) under controlled condi-
tions (22°C±3°C, in a 12-hour light/dark cycle, with free 
access to food and water). Animal care, research, and animal 
euthanasia protocols were performed in accordance with the 
principles and guidelines adopted by the Brazilian College 
of Animal Experimentation (COBEA) and approved by the 
Institute of Biology/UNICAMP – Ethical Committee for 
Animal Research (number 1900-1). Prior to the experimental 
tests, rats were fasted for 12 hours with water ad libitum. 
Ultrasonication of freeze-dried particles (sponge) in saline 
provided the NP samples used in both tests.
ethanol-induced gastric ulcer
Animals were separated into six groups (number [n]=6) 
and orally treated with saline (NaCl 0.9%) 10 mL⋅kg-1, 
carbenoxolone 200 mg⋅kg-1, nonloaded NPs 300 mg⋅kg-1, 
and A. chica NPs in three different doses (30 mg⋅kg-1, 
100 mg⋅kg-1, or 300 mg⋅kg-1). One hour after treatment, all 
rats orally received 1 mL of absolute ethanol. After 1 hour, the 
animals were euthanized by an overdose of thiopental and their 
stomachs were removed, by opening them along the greater 
curvature, and washed. After washing the stomachs with 
saline solution, the ulcerative lesion index (ULI) was scored as 
described by Vendramini-Costa et al23 using the arbitrary scor-
ing system shown in Table 1. Gastroprotection was calculated 
by comparing the treatment group with the negative control 
(saline solution) group, using the following formula:
 Gastroprotection (%)
Average control  
average treatment 
A
=
−
verage control
×100.  (4)
Indomethacin-induced gastric ulcer
Rats were distributed into three groups (n=6) according to 
the treatment employed: saline (NaCl 0.9%) 10 mL⋅kg-1, 
ranitidine 50 mg⋅kg-1, and A. chica NPs 200 mg⋅kg-1. 
One hour after oral treatment, animals received an intra-
peritoneal dose of indomethacin (30 mg⋅kg-1). After 
6 hours, the rats were euthanized by an overdose of thiopen-
tal. The stomachs were removed, by opening them along the 
greater curvature, and washed. After washing the stomachs 
with saline solution, the ULI was calculated as described in 
the ethanol-induced gastric ulcer procedure.
statistical analysis
The CV results are presented as the mean ± SD (n=8). 
Averages were compared by one-way analysis of variance 
(ANOVA) followed by t-tests. Data from the ulcer experi-
mental test are shown as the mean ± standard error of the 
mean of the six animals per group. Averages were compared 
by ANOVA followed by Tukey’s post hoc test for multiple 
comparisons. Differences were considered significant if the 
P-value was ,0.05.
Table 1 scoring system employed for the determination of the 
ulcerative lesion index in gastric ulcer induction models
Parameter Score
loss of normal morphology 1
Discoloration of mucosa 1
edema 1
hemorrhages 1
Petechial points (#10) 2
Petechial points (.10) 3
Ulcers up to 1 mm n×2
Ulcers .1 mm n×3
Perforated ulcers n×4
Abbreviation: n, number of ulcers found.
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Results and discussion
Phytochemical analysis
Standardization of plant inputs for the pharmaceuticals 
industry plays an important role in product outcomes. Factors 
such as soil, climate conditions, genotypes, harvesting, and 
postharvest conditions have been shown to have an important 
influence on both chemical and biological activity. Therefore, 
the quality of the botanical material, as well as the adequate 
processing of the fresh material, including drying, transpor-
tation, storage, and the use of appropriate and reproducible 
extraction techniques have a straight outcome on health ben-
efits and economic issues.24 Previous studies were conducted 
to determine the best conditions for AcE preparation.3,18,25–27 
Anthocyanins are the most common pigments in nature 
and can be extracted with acidified solvents such as water, 
acetone, ethanol, methanol, or mixtures of aqueous solvents.28 
The crude extract was obtained using a 70% ethanol solution 
with 0.3% citric acid. Methanol is indeed the most common 
and effective solvent for extracting anthocyanins; however, 
it is an environmental pollutant and it is also more toxic than 
other alcohols. Thus, ethanol is preferred over methanol for 
the extraction of anthocyanins from plant material.28 Citric 
acid is important for stabilizing anthocyanin in the normal 
extraction process without interfering with the pharmacologi-
cal activity. Barros et al29 reported that citric acid was capable 
of improving 3-deoxyanthocyanidin extraction yield.
The presence of 6,7,3′,4′-tetrahydroxy-5-methoxy-
flavylium, 6,7,4′-trihydroxy-5-methoxyflavylium, and 
carajurin (Figure 1), compounds with straight relationship 
with A. chica extract activity,26 was monitored by HPLC-
DAD analysis. The carajurin content was determined as 
6.51%±0.07% yield.
Preparation of cs-TPP NPs
Ionotropic gelation involves the spontaneous aggregation 
of CS with multivalent counter ions, most commonly TPP. 
NPs were formed immediately upon mixing TPP and CS 
solutions as molecular linkages between TPPs and CS 
amino groups.30,31 The adjustment of parameters such as 
CS concentration, the CS:TPP polymer ratio, and mixing 
conditions control CS-TPP NP size.32–34
Initial studies aiming to optimize NP formation were 
conducted. Particle size and particle size and polydispersity 
were measured with a Zetasizer Nano. Particles of 150 nm 
were produced by employing a CS-TPP mass ratio of 5. 
Mass ratios of 7, 10, or 20 resulted in particles 387–681 nm 
in size (Table 2).
Particle size increased with an increasing CS-TPP mass 
ratio, as described by Gan et al30 and Li and Huang;35 this is 
oppossed to data reported by Konecsni et al.36 The NP suspen-
sion became turbid as the CS-TPP mass ratio was reduced 
to 1, indicating the production of large particles. A similar 
phenomenon was observed by Hu et al37 where aggregates 
with a large diameter were formed when the CS-TPP mass 
ratio was decreased to 1.5. The optimized CS-TPP mass ratio 
was reported as 537 and 3.75.35 Our studies indicated that CS 
concentrations of 1 mg⋅mL-1, with a CS-TPP polymer ratio 
(w:w) of 5, a CS-TPP volume ratio of 10, and using mechani-
cal stirring at 7,200 rpm, followed by sonication (5 minutes, 
20% amplitude) resulted in the reproducible formation of 
NPs with an average hydrodynamic diameter of 150±13 nm 
and a ZP of +45±2 mV, with high yields (75%).
The ZP reflects the electrical superficial charge of par-
ticles and is influenced by the particle composition and the 
dispersion medium.38 This parameter is used as a NP stabil-
ity index. The electronic repulsion between particles can 
greatly affect the particle stability in suspension. As a result, 
a higher absolute ZP value indicates a more stable suspension, 
whereas a lower value implicates colloid instability, which 
could lead to NP aggregation.39 NPs with a ZP above ±30 mV 
have shown to be stable in suspension, as the surface charge 
prevents aggregation of the particles.38
encapsulation of A. chica extract
AcE was added to TPP aqueous solution in different concen-
trations in relationship to CS (w/w) for AcE-NP production. 
The size, polydispersity index, and ZP were measured by a 
Zetasizer Nano (Malvern Instruments) (Table 3).
? ???
? ? ?
??
?? ??
??
??
??
??
??? ???
???? ? ??
??
???
Figure 1 chemical structure of 3-deoxyanthocyanidins: pigment 1 (6,7,3′,4′-tetrahydroxy-5-methoxyflavylium), pigment 2 (6,7,4′-trihydroxy-5-methoxyflavylium), and 
pigment 3 (carajurin).
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The particle size decreased with AcE concentration 
increases, suggesting an interaction between the extract’s 
composition and the polymers. A similar effect was reported 
for Camellia sinensis catechins. According to Hu et al,37 the 
mean diameter of CS-TPP NPs loaded with C. sinensis cat-
echins was smaller to that of the corresponding CS-TPP NPs, 
which may be attributable to a greater cross-linking density 
of the tea catechin-loaded NPs caused by the interactions 
between the CS matrix and catechins.
The ZP values were positive for all compositions, indi-
cating a positively charged surface. The NPs demonstrated 
higher +30 mV ZP, ensuring particle stability.
Encapsulation efficiency
The measurement of the amount of the drug released (nonen-
trapped AcE) in the external aqueous solution recovered after 
NP dialysis permitted the determination of AcE entrapped 
within the polymeric NPs as 84% yield. Considering the AcE 
amount added during NP production and the EE, the ratio of 
AcE loaded in the NPs was 20%.
Evidence for the encapsulation of AcE was provided by 
Fourier transform infrared spectroscopy (Supplementary 
materials, Figure S1).
Morphological characteristics of ace-NP 
and sponges
The NPs were predominantly spherical (Figure 2). The size 
was approximately 60 nm, which is consistent with the results 
obtained by light scattering.
The NP dispersion was directionally frozen in liquid 
nitrogen and then freeze-dried, forming sponge-like struc-
tures. The sponge’s morphology was determined by SEM, 
by direct surface analysis (Figure 3). Some groups40–42 have 
reported the preparation of porous structures via unidirec-
tional freezing, where the physics of ice formation can be 
used to develop sophisticated porous materials with a process 
that does not involve any chemical reaction. The method 
consists of freezing the colloidal aqueous suspensions. This 
relatively simple technique has the potential to produce 
complex, multicomponent, aligned structures for several 
applications.
CS sponges have been widely used as tissue engineer-
ing scaffolds, owing to their simple fabrication, efficient 
aqueous absorption, and porous structure enabling cell 
penetration.43 Noel et al44 and Smith et al45 suggested the 
possibility of using a CS sponge device as an alternative to 
deliver antibiotics locally as an adjunctive therapy for the 
treatment and prevention of infections, from open traumatic 
Table 2 average particle size and polydispersity measured with a 
Zetasizer Nano (Malvern Instruments, Malvern, UK)
CS-TPP mass ratio Size (nm) Polydispersity
20 681±16 0.59±0.1
10 473±8 0.24±0.03
7 387±10 0.26±0.04
5 150±13 0.18±0.02
4 230±15 0.23±0.05
Notes: Values are shown as the mean ± standard deviation; n=5.
Abbreviations: cs, chitosan; TPP, sodium tripolyphosphate; n, number.
Table 3 average particle size, polydispersity index, and zeta 
potential values measured with a Zetasizer Nano (Malvern Instru-
ments, Malvern, UK)
Proportion  
of CS/AcE
Size  
(nm)
Polydispersity Zeta potential 
(mV)
Without ace 150±13 0.18±0.02 +45.0±2
10% 153±9.3 0.24±0.03 +32.7±1.8
15% 125±7.8 0.26±0.04 +32.1±0.8
25% 60±10.2 0.3±0.1 +32.9±1.5
Notes: Values are shown as the mean ± standard deviation; n=5.
Abbreviations: cs, chitosan; ace, Arrabidaea chica extract; n, number.
???????
?????????????????????????????????????????????????? ??????
Figure 2 Images of Arrabidaea chica nanoparticles obtained by scanning electron 
microscopy.
??????????????????????????????????????????????? ??????
Figure 3 scanning electron micrograph of freeze-dried Arrabidaea chica nanoparticles 
(sponge).
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wounds to prophylactic use in surgical sites. Furthermore, 
a CS sponge can be used as a drug reservoir43 or a storage 
form for CS systems. The sponges reported herein were used 
as an NP storage form; therefore, they can return to the NPs 
through ultrasonication. Additional studies will be required 
to determine the best conditions to prepare CS standardized 
scaffolds.
Biocompatibility of NPs
One of the most popular and convenient ways to determine 
CV is the rapid colorimetric tetrazolium dye procedure com-
monly referred to as the MTT assay. This assay is based on 
the cleavage of the yellow-colored tetrazolium salt, 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, 
into a blue-colored formazan by the mitochondrial enzyme 
succinate-dehydrogenase.46
In order to disregard any cytotoxic product’s influence 
on fibroblast proliferation, an MTT assay was conducted 
with NPs, AcE-NPs, and AcE (0.5 mg⋅mL-1) that stayed in 
contact with the culture medium for determined time periods 
(1–21 days). The results are shown in Figure 4.
The CV was approximately or higher than 80% in all 
cases; according to assessment of the standard ISO 10993-
5:2009,47 biocompatibility was not compromised. Thus, 
under the experimental conditions, the samples did not 
produce cytotoxic products.
To evaluate the sample’s CV by direct contact, an MTT 
assay was conducted in which the fibroblasts were exposed to 
samples by 24 hours, 48 hours, or 72 hours (Figure 5). The NPs, 
AcE-NPs, and AcE at 0.001–0.125 mg⋅mL-1 concentrations 
showed the same viability profile of approximately 100%.
The 30% CV, which is in comparison to the control of 
AcE at 0.5 mg⋅mL-1, might have a relationship with the 
antioxidant components of the extract. According to Heim 
et al,48 pro-oxidant effects have shown to be involved with 
cytotoxic and proapoptotic effects of flavonoids isolated from 
plants. Therefore, this information suggests that a molecule 
with the same chemical structure can optimize antioxidant 
capacity and it may also exacerbate oxidative stress and 
damage to functional and structural cellular molecules.48 
However, considering the role of flavonoid’s radical stability 
in pro-oxidant behavior postulated by Bors et al49 structural 
advantages to radical stability that increase antioxidant activ-
ity, such as a 3′4′-catechol, 3-OH, and conjugation between 
the A- and B-rings, may modulate the adverse oxidative 
effects of flavonoids.
Pro-oxidant properties seem to have a direct relation-
ship with flavonoid concentration.50 At a concentration of 
0.250 mg⋅mL-1, A. chica free extract demonstrated 90% 
CV, whereas at 0.5 mg⋅mL-1, CV decrease to 20%. A study 
described by Procházková et al50 reported that 1–50 µM of 
quercetin decreased DNA oxidative damage, whereas 100 µM 
increased damage. This observation demonstrated the pro-
oxidative effect of the highest concentration employed. 
Nevertheless, quercetin maintained the antioxidant activity 
when encapsulated in the CS-TPP NPs.51
Herein, AcE-NPs showed different behavior when com-
pared to the free extract, demonstrating the capability of 
maintaining CV at the lowest concentrations tested; likewise, 
they stimulated cell proliferation at higher concentrations, 
confirming the positive association of nanotechnology with 
herbal medicine. The AcE-NP proliferative activity indicated 
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Figure 4 Fibroblast viability in the presence of chitosan NPs, ace, or ace-NP at 0.5 mg⋅ml-1.
Notes: Data are presented as the mean ± standard deviation (n=8). statistical analysis was performed using a one-way aNOVa followed by a student’s t-test. *Significant 
difference between the ace-NP and the control was P,0.05.
Abbreviations: NP, nanoparticle; ace, Arrabidaea chica extract; ace-NP, Arrabidaea chica extract nanoparticle; n, number; aNOVa, analysis of variance.
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that AcE encapsulation in CS NPs may be a useful approach 
for improving A. chica biocompatibility.
antiulcerogenic activity
The antiulcerogenic activity of A. chica NPs was evaluated 
with acute gastric ulcers induced by ethanol and indometha-
cin experimental models.
The acute lesions on the gastric mucosa caused by ethanol 
ingestion involve mucus destruction and the release of free 
radicals, playing a vital role in altering the stomach’s natu-
ral defense mechanisms. The ethanol-induced gastric ulcer 
experimental model is a simple and reproducible procedure 
and, therefore, may be considered a test of choice for screen-
ing samples with possible antiulcerogenic effects.52,53
The gastroprotective activity of A. chica extract in 
ethanol-induced ulcer formation in rats was previously 
reported by Jorge,54 employing 100 mg⋅kg-1, 300 mg⋅kg-1, and 
1,000 mg⋅kg-1 doses, revealing 125 mg⋅kg-1 as the effective 
dose to promote 50% gastroprotection. Herein, CS NPs loaded 
with A. chica extract reduced the ULI using lower doses 
(30 mg⋅kg-1, 100 mg⋅kg-1, and 300 mg⋅kg-1). The 30 mg⋅kg-1 
dose was sufficient to reduce 58% of the ULI in comparison 
to the control group (saline) (Figure 6, Figure S2).
The doses used in the present research refer to the amount 
of NPs. Therefore, when extrapolating the amount of A. chica 
loaded in those particles, the amount of tested plant extract 
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Figure 5 Fibroblast viability in relation to 24-hour, 48-hour, or 72-hour exposure to chitosan NPs, ace, or ace-NPs.
Notes: (A) 24 hours; (B) 48 hours; (C) 72 hours. Data are shown as the mean ± standard deviation (n=8). statistical analysis was performed using a one-way aNOVa 
followed by a student’s t-test. *P,0.01; **P,0.001.
Abbreviations: NP, nanoparticle; ace-NP, Arrabidaea chica extract nanoparticle; ace, Arrabidaea chica extract; n, number; aNOVa, analysis of variance.
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Figure 6 Ulcerative lesion index of nonloaded NPs and ace-NP on ethanol-induced 
gastric ulceration in rats.
Notes: Data are shown as the mean ± standard error (n=6). statistical analysis was 
performed using a one-way aNOVa followed by Tukey’s test. ***P,0.001 compared 
with negative control (saline). carbenoxolone was used as a positive control.
Abbreviations: NP, nanoparticle; ace-NP, Arrabidaea chica extract nanoparticle; 
n, number; aNOVa, analysis of variance.
is considerably smaller. The proportion of A. chica extract 
present in the NPs was 20%; that is, the highest tested dose 
(300 mg⋅kg-1) corresponded to approximately 60 mg⋅kg-1 
of plant extract. These results suggest that extract encapsu-
lation in CS NPs allows for a dose reduction for the same 
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pharmacological gastroprotective effect when compared to 
the free extract.
A similar phenomenon was described by Strasser et al55 
where the nanoencapsulated Passiflora serratodigitata L. 
extract had greater antiulcerogenic activity than their con-
ventional extract forms.
In order to evaluate the gastroprotective effect of the 
A. chica NPs through a systemic gastric ulcer model, an 
indomethacin-induced gastric ulcer was performed. The 
integrity of gastric mucosa against ulcerogenic and necrotiz-
ing agents depends on the generation of prostaglandins by 
cyclooxygenase-1 (COX-1). Indomethacin is a nonsteroidal 
anti-inflammatory drug that potently damages prostaglandin 
synthesis by COX inhibition.56 The gastroprotective effect of 
the A. chica NPs (200 mg⋅kg-1) reduced 58% of the nonsteroi-
dal anti-inflammatory drug-induced lesion when compared 
to the negative control group (Figure 7).
The pharmacological effect of A. chica NPs in both 
ethanol- and indomethacin-induced gastric ulcer models 
represents promising results and, therefore, deserves further 
investigation.
Nanostructured systems might be able to potentiate the 
action of plant extracts, reducing the required dose and side 
effects, thus improving activity.9 The AcE-NP antiulcer 
effect indicated that AcE encapsulation in CS NPs may be 
an useful approach for improving A. chica applicability for 
ulcer-healing pharmaceutical systems.
Conclusion
The CS-TPP NPs and CS-TPP NPs loaded with AcE were 
successfully prepared based on the ionic gelation between CS 
and TPP. The CS-TPP mass ratio of 5 and volume ratio of 
10 were found to be the best condition to achieve the lowest 
NP sizes. Particle size decreased with AcE addition, sug-
gesting an interaction between the extract’s composition and 
polymers. The A. chica NPs showed good biocompatibility, 
which was demonstrated in CV studies and antiulcerogenic 
activity in rat experimental models. The AcE encapsulation 
offers an approach for the further application of A. chica 
extract that could be considered a potential candidate for 
ulcer-healing pharmaceutical systems.
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Supplementary materials
Fourier transform infrared spectroscopy 
fitted with attenuated total reflectance
Attenuated total reflectance Fourier transform infrared 
spectroscopy (ATR-FTIR) spectra were recorded on a 
PerkinElmer Spectrum One spectrophotometer (PerkinElmer 
Inc., Waltham, MA, USA). Infrared spectra were obtained 
between 4,000 cm-1 and 650 cm-1 by 32 scans and with a 
scanning resolution of 4 cm-1.
FTIr characterization of nanoparticle 
systems
The FTIR spectra (Figure S1) of nanoparticle (NP) systems 
loaded with Arrabidaea chia extract (AcE) showed the char-
acteristic bands of its main components, chitosan and AcE.
The spectrum of AcE showed typical aromatic bands, 
belonging to aromatic rings, at 1,580 cm-1. Empty NPs 
formed by partially cross-linked chitosan showed the stretch-
ing hydroxyl and amino bands at 3,414 cm-1 and 3,215 cm-1, 
respectively. At 2,884 cm-1, it can be observed that the 
stretching bands of C–H bonds belong to the chain polymer. 
The characteristic carbonyl (C=O) and amino (N–H) tension 
and torsion bands appeared at 1,664 cm-1 and 1,574 cm-1, 
respectively. At 1,423 cm-1, it showed the torsion band 
of the -CH
2
– groups, and at 1,316 cm-1, the C–N tension 
band appeared. The symmetric stretching belonging to the 
C–O group appeared at 1,074 cm-1 and the glycoside bond 
(C–O–C) showed stretching bands at 894 cm-1 and 705 cm-1. 
In the AcE-loaded NP spectrum, a slight deviation of the 
hydroxyl (OH) and amino (NH
2
) bands was observed, 
appearing at 3,200 cm-1, which corresponds to a mean value 
between the empty NP (3,260 cm-1) and AcE (3,198 cm-1) 
bands. C–H stretching bands of the chain polymer appeared 
at higher wave numbers (2,924 cm-1) due to the presence of 
a positive oxygen in the AcE structure. Besides, the carbonyl 
and amino tension and torsion bands of chitosan were nearly 
overlapped in the AcE-loaded NP spectrum due to the influ-
ence of aromatic ring bands belonging to AcE.
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Figure S1 Fourier transform infrared spectra of ace, chitosan NPs, and ace-NPs.
Abbreviations: ace-NP, Arrabidaea chica extract nanoparticle; ace, Arrabidaea chica extract; NP, nanoparticle.
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Figure S2 stomachs opened along the greater curvature in ethanol-induced gastric ulcer.
Notes: stomachs of rats orally pretreated with (A) negative control, (B) nonloaded nanoparticles, (C) carbenoxolone, and Arrabidaea chica nanoparticles at (D) 30 mg⋅kg-1, 
(E) 100 mg⋅kg-1, and (F) 300 mg⋅kg-1 doses.
